Significantly More TIF/Placebo Patients Experienced Elimination of Troublesome Regurgitation as Compared to Sham/PPI Patients SAN MATEO, Calif.–EndoGastric Solutions (EGS) announces that Gastroenterology, the official journal of the American Gastroenterological...
Now physicians can utilize the latest-generation high definition (HD) endoscopes when performing Transoral Incisionless Fundoplication (TIF®) procedures to treat the underlying, anatomical causes of GERD SAN MATEO, Calif. (Dec. 10, 2014)–EndoGastric Solutions® (EGS),...
EndoGastric Solutions Reports Two-Year Durability Data from TIF Registry for GERD Patients Choosing Transoral Incisionless Fundoplication (TIF®) SAN MATEO, Calif. (Oct. 29, 2014)–EndoGastric Solutions® (EGS) announced publication of US registry data showing that...
Six-month results of the first-ever sham and placebo-controlled study of a transoral endoscopic procedure for GERD presented at American College of Gastroenterology (ACG) 2014 Annual Scientific Meeting SAN MATEO, Calif. (Oct. 20, 2014)–EndoGastric Solutions (EGS)...